Introduction
Haemoglobin (Hb) is commonly used to measure anaemia status using an automated haematology analyser [1] but this requires both blood withdrawal and access to laboratory facilities. In developing countries, many individuals, often those with greater health needs, do not have easy access to diagnostic facilities [2] . Recently, the non-invasive haemoglobin sensor NBM 200 was introduced for Hb assessment, which provided an opportunity for anaemia screening at population level in developing countries [1, 2] . The NBM 200 sensor is a non-invasive portable device consisting of a finger probe and a processing unit with digital display. The finger-blood analyser uses occlusion spectrometry to estimate Hb in approximately 60 to 100 seconds [3] .
Recent studies conducted to validate NBM 200 mainly involved blood donation centers within hospital settings [4] . There is a strong clinical need to measure Hb levels accurately in settings where laboratory access is not easy, particularly during pregnancy where repeated measurements are required. However, there are no published evidences on the application of non-invasive Hb sensors outside hospital settings for antenatal anaemia screening [2, 4] .
Thus it is an important area of research considering the high prevalence of anaemia in women during pregnancy in country like India [5, 6] . Moreover, there is little evidence for the accuracy of non-invasive haemoglobin sensors used in rural community settings. Therefore, the present study aimed to assess non-invasive haemoglobin measurements (using the NBM 200 sensor) against measurements obtained from a gold standard method using an automated haematology analyser (Sysmex XP-100) [7] among pregnant women living in rural India.
Materials and Methods
A cross-sectional study was conducted in 33 villages from Tuljapur and Lohara blocks, Osmanabad district, in the Indian state of Maharashtra with a catchment population of approximately 64,000 individuals. The primary aim of the study was to investigate the prevalence and risk factors of anaemia in pregnant women; this paper reports on a secondary aim which was to validate the use of the non-invasive Hb sensor NBM 200 as a screening test for anaemia in this population. The study population consisted of pregnant women between 3 to 5 months of pregnancy who provided data in the period 24 th April 2014
to 30 th June 2015. Each participant was recruited after obtaining written consent in the presence of a witness and the primary investigator (AA). Trained data assistants obtained the non-invasive haemoglobin measurements in accordance with manufacturer's guidelines for the NBM 200 (Orsense Ltd, Nes-Ziona, Israel). Exclusion criteria were physical deformity of thumb of a non-dominant hand, any injury/ulcerations, localized infection, edema and skin breaks [8] . The gold standard measurement was obtained using a fully automated haematology analyser (Sysmex XP-100, Japan) on a venous blood sample at the haematology laboratory based in the Halo Medical Foundation's (HMF) registered hospital at Andur, Maharashtra [7] . The non-invasive test was conducted in a sitting position in field (either at the participant's home or in village health/nutrition center) followed by blood withdrawal within a 5-minutes interval [9] . For every participant, the non-dominant hand was used for venous blood withdrawal from the median cubital vein and the thumb of the same hand was used to obtain the non-invasive measurement [9] . The venous blood was obtained under an aseptic protocol using a 2-mL disposable sterile syringe. Each participant was asked to wait for 10 minutes after completion of both tests to ensure no adverse effect occurred post blood withdrawal. The blood sample was transferred to a 2-mL vacuum tube containing ethylenediaminetetraacetic acid (EDTA anticoagulant), which was then safely transported in a standard blood carrier container and tested in the HMF laboratory using Sysmex XP-100 within four hours of withdrawal. The analyser was calibrated everyday according to the manufacturer's guidelines and standard laboratory protocol [7] .
Hb measurements obtained from each method were used to categorise each participant as having anaemia (Hb < 11 g/dL) or not [10] . We also classified participants as having severe anaemia if their Hb values were less than 7.0 g/dL [10] . Spearman's rank correlation coefficient (r s ) and Interclass correlation coefficient (ICC) was used to assess correlation and accuracy respectively, between the Hb measurements obtained from the two methods.
Agreement between two methods was further investigated using the Bland-Altman analysis [11] . The diagnostic accuracy of the NBM 200 was then assessed against the Sysmex XP-100 (the gold standard comparison in our study) [7] . 
Discussion
In this study involving women during pregnancy, we found that haemoglobin measurements obtained from the NBM 200 were generally higher than the measurements obtained from the Sysmex XP-100 (gold standard). Consequently, the NBM 200 grossly underestimated the anaemia prevalence in our study population (sensitivity of 33.7%). The ICC indicated fair agreement for NBM 200, however we identified possible patient safety concerns with the use of the NBM 200, considering all the severe anaemia cases in our study participants were misclassified as having moderate anaemia and would not have received appropriate clinical intervention had this method alone been used (Table 1) .
Our study has many strengths; to our knowledge it is the first where prospectively collected data are presented from a large representative population of pregnant women in a rural community setting [4] . The study population was drawn from marginalised and difficult to access areas where comparatively few healthcare facilities are available, and thus evaluating non-invasive portable technology in geographically remote areas is highly important. Secondly, our study recorded good response rate (96.8%), with only seven eligible women declining to participate. Lastly, the non-invasive readings were obtained in accordance with the manufacturer's guidelines, and none of our subjects had thumb deformity, infection, ulcerations, edema, or skin colourants such as henna (locally known as Mehndi) [12] . However, a technical failure of the non-invasive sensor occurred twice during the study, which delayed data collection, and caused the loss of two samples as mentioned before.
Our study findings are in agreement with those from a study conducted at a blood center in Seoul, Korea by Kim et al. [13] where the NBM 200 Hb measurements tended to be higher than the LH500 automated hematology analyser estimates (Beckman Coulter Inc., Brea, CA, USA). The sensitivity (38.6%) and specificity (93.6%) analyses were very similar to our study and indicated that the NBM 200 failed to detect more than half of the ineligible blood donors. Though the correlation between these two techniques was satisfactory (r s 0.86), the strong agreement may not be the criteria for donor selection, as accurate blood parameters are prerequisites to prevent any ineligible donor selection. Similarly, an Italian study (n= 3995 donors) showed a low sensitivity using NBM 200 (36.03% in men group and 45.76% among women) on comparison with the gold standard Beckman Coulter's AcT-5 diff AL (Beckman Coulter Inc., Brea, CA, USA) [14] . However, our findings are in contrast to a recent study involving blood donors (n= 485, 94% men) from North India that reported a 71.7% sensitivity for the NBM 200 when compared with the Sysmex KX-21 analyser (Sysmex Corporation, Kobe, Japan) ( Table 2 ) [5] . Despite the high sensitivity, the Bland Altman limits of agreement were wide (Upper limit of agreement: 2.09 and Lower limit of agreement: -3.39) with poor correlation (r s = 0.43) between the two Hb estimation methods.
About 45.5% of ineligible donors were not detected in the Indian study [5] , similar to the study by Kim et al [13] . A second study from Northwest India [6] and specificity (97%) in a similar study population. It is worth noting however, that all the patients in their study had Hb values above 13 g/dL (as ascertained using the Beckman Coulter AcT-5 diff cell counter) and unlikely to be representative of the general population.
A study [8] involving pregnant women from Israel (n=63) reported Hb in the range 6.9 g/dL to 13.9 g/dL by the gold standard (LH750 analyser, Beckman Coulter Inc., Brea, CA, USA), which was lower than the range reported by the NBM 200 (7.7 g/dL to 14 g/dL). The Bland Altman analysis showed wide limits of agreement (-1.59 to 1.79) with a standard deviation error of 0.86 g/dL. The study concluded that the sensor measures haemoglobin accurately mainly based on a strong correlation, however, correlation measures association and not agreement [11, 13] . Secondly, the range of Hb values obtained by the gold standard and NBM 200 clearly indicate that the NBM 200 missed some severe anaemia cases similar to our experience [8] . Lastly, the study involved pregnant women from all trimesters (gestational age: average 35.9 weeks, range 13 to 41 weeks), where Hb is likely to vary [9] , while our findings are based on larger sample size (n=269) between a fixed gestational period (3 to 5 months of pregnancy) and included a more detailed diagnostic analysis reporting the Bland Altman agreement method, sensitivity, specificity, NPV, PPV and correlation analyses.
Previously published studies of the NBM 200 sensor (Table 2 ) have been mostly conducted in prospective blood donors [5, 6, 12, 14, 15] , in whom Hb is likely to be higher than the general population. Moreover, the two Indian studies outlined earlier, had fewer than 7%
women participants [5, 6] . A report from Indian National Family Health Survey 2005-06
showed a 24% anaemia prevalence in men (aged 15-49 years), which was much lower than in women (55% prevalence, 15-49 years) [16] . Based on our results, the NBM 200 underestimates anaemia prevalence; therefore, the validation of the non-invasive technology predominantly in male blood donors could explain the different findings. The study by Singh et al. had a prevalence of 2.3% anaemic cases identified by the gold standard [5] , and the study by Malukani et al. had only 17% anaemic cases [6] as compared to our study with 77.3% anaemic cases, suggesting sampling variability [4] . Studies from Italy, Germany and
France involved fairly equal number of men and women reporting to blood donation centers, but anaemia prevalence is much lower in these countries compared to India. The German study reported a mean haemoglobin value of 13.4 g/dL (SD 0.93) in women (using gold standard, Sysmex KX-21) [12] , while in our study settings in rural India mean haemoglobin was 10.0 g/dL (using gold standard, Sysmex XP-100). Similarly, the mean haemoglobin in the French study was 13.2 g/dL (95% CI: 11.9, 14.3) [1] and in the Italian study the boxplot indicated a mean Hb of 14.0 g/dL [15] . A systematic review and meta-analysis by Kim et al.
[4] of non-invasive Hb sensor technologies (Radical 7, NBM 200, Pronto 7 and NBM 200MP)
found that the pooled mean difference and SD were 0.10, + -1.37 g/dL respectively (95% CI: -2.59, 2.80, I 2 = 95.9% for mean difference and I 2 =95.0% for SD). The review concluded that because of the wide limits of agreement with reference methods, clinical decisions based on non-invasive devices should be made cautiously. All studies included in the review were hospital-based, and none of the studies were from developing countries where anaemia prevalence is typically much higher.
Conclusions and implications
This is the first study conducted in a rural community setting where a representative sample of pregnant women was assessed. Our measurements were obtained in the field during a household survey which provided a unique opportunity to test the non-invasive technology in rural areas, where diagnostic facilities are limited. Globally, anaemia is a major public health Financial disclosure: Donors/Organisations/Individuals outlined above have had no role in defining the study hypothesis, data collection, data analysis, interpretation or manuscript preparation.
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